Sunday, May 27, 2018
 
 
Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Tower Urology Offers GAINSWave® in Los Angeles
 
(May 16, 2018)

LOS ANGELES, May 16, 2018 /PRNewswire/ -- Tower Urology is pleased to announce they now offer GAINSWave! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance and to treat Erectile Dysfunction (ED) symptoms.

GAINSWave Logo (PRNewsfoto/GAINSWave)

As men age, the vessels in their penis weaken, contract and fill with micro-plaque, which can lead to Erectile Dysfunction. As these tiny vessels become clogged, the penis decreases in sensitivity, making it harder for men to achieve and maintain an erection. Thankfully, the GAINSWave protocols can enhance a man's performance by using high-frequency acoustic waves to repair existing blood vessels and improve blood flow.



Thanks to the numerous  clinical studies on Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT), we can see that this therapy improves not only Erectile Dysfunction symptoms but also sexual performance. "GAINSWave is an ideal solution for men looking to improve spontaneous erections without the use of Viagra or Cialis," says Premal Desai, MD. Patients receiving GAINSWave therapy have reported improved erection quality, enhanced sexual performance and decreased refractory times between orgasms, which is why this a great alternative to ED medications.

This drug and surgery-free procedure only takes about 20 minutes and can enhance a man's sex life while addressing the root cause of Erectile Dysfunction. Tower Urology is now treating men with the GAINSWave Therapy in their offices located at 8635 W 3rd St, Los Angeles, CA 90048, USA.

Tower Urology was born approximately fifty years ago. At the end of World War II, Dr. Barney Silver, returned from service in the South Pacific and started his urologic practice at the old Cedars of Lebanon Hospital on Sunset Boulevard.

The practice continued to grow rapidly allowing for the addition of Dr. Stuart (Skip) Holden, Dr. Stephen (Buddy) Sacks, Dr. Norman Nemoy, Dr. Arnold Cinman and Dr. Sharron Mee, the first female urologist at Cedars-Sinai Medical Center. Tower Urology has a patient base in excess of 40,000, and continues to see about 4,000 new patients per year. Of the surgical and office procedures done routinely today by the Tower Urology, many are new and innovative, introduced within the last ten years and include: extracorporeal shock wave lithotripsy (ESWL) – the non-surgical treatment of kidney and ureteral stone disease; lasers in the management of stone, bladder and prostate disease; laparoscopy; innovative approaches in the treatment of prostatic and bladder cancers, sexual dysfunction with the use of injectables and implants; kidney and prostate ultrasound; tomography; sophisticated chemical diagnostic testing, microwave therapy for BPH and biofeedback for incontinence.

For More Information Contact:
Alexandra Schapiro
Marketing Account Manager
[email protected]
305-918-1886

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/tower-urology-offers-gainswave-in-los-angeles-300649954.html

SOURCE GAINSWave

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science,Medical,Men,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Bellevue Asset Management AG: Bellevue launches dedicated digital health fund
  • Global Chromatography Reagents Market Analysis, Growth, Trends & Forecast 2018-2023, With The Market Forecasted to Register a CAGR of More Than 7% - ResearchAndMarkets.com
  • Life Science Reagents Market to exceed US$ 67.0 Bn by 2026, Says TMR
  • Study on Poor Oral Hygiene Habits of Aging Population Underlines the Importance of Outstanding Dental Care, says Premier Care Dental Group
  • Blood Gas and Electrolyte Analyzer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2023

    Cancer
  • Genmab Announces that Janssen Will Stop Studies of Daratumumab in Combination with Anti-PD-(L)1
  • NASP Applauds Bipartisan Legislation Introduced to Reduce Drug Costs and Support Access for Seniors with Life-Threatening Specialized Conditions
  • Celgene Corporation Announces Additional $3 Billion Share Repurchase Authorization and Plans to Execute a $2 Billion Accelerated Share Repurchase Program
  • Moorestown Visiting Nurse Association joins the growing enTouch network in New Jersey
  • Achieve Life Sciences, Inc. Announces Reverse Stock Split
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines